Assessing drug-likeness--what are we missing?

Drug Discovery Today
Giulio VistoliBernard Testa

Abstract

The concept of drug-likeness helps to optimise pharmacokinetic and pharmaceutical properties, for example, solubility, chemical stability, bioavailability and distribution profile. A number of molecular descriptors have emerged as reasonably informative and predictive, for example, the Rule-of-Five. Here, we review some current approaches, then discuss their major shortcoming, namely the static nature of the structural features and physicochemical properties they encode. As we demonstrate, molecules are not 'frozen statues' but 'dancing ballerinas', and several of their computable physicochemical properties are conformation-dependent and lead to the concept of property spaces. Molecular sensitivity (namely, how much a given computable physicochemical property varies as a function of flexibility) appears as a promising descriptor to encode some of the information contained in molecular property spaces.

References

Apr 1, 1994·Journal of Computer-aided Molecular Design·P GaillardA Boudon
Aug 28, 1998·Journal of Medicinal Chemistry·A AjayM A Murcko
Aug 28, 1998·Journal of Medicinal Chemistry·J Sadowski, H Kubinyi
Jun 21, 2001·Journal of Chemical Information and Computer Sciences·M M HannG Harper
Oct 18, 2001·Journal of Chemical Information and Computer Sciences·T I OpreaP D Leeson
May 31, 2002·Journal of Medicinal Chemistry·Daniel F VeberKenneth D Kopple
Jun 20, 2002·Journal of the American Chemical Society·Giulio VistoliBernard Testa
Sep 5, 2002·Nature Reviews. Drug Discovery·Andrew L Hopkins, Colin R Groom
Nov 5, 2002·Journal of Molecular Graphics & Modelling·Alessandro PedrettiGiulio Vistoli
Jan 28, 2003·Journal of Chemical Information and Computer Sciences·Miklos Feher, Jonathan M Schmidt
Aug 9, 2003·Nature Reviews. Drug Discovery·Hugo Kubinyi
Dec 30, 2003·Journal of Medicinal Chemistry·Michal ViethPhilip A Hipskind
Feb 27, 2004·Pharmaceutical Research·Sandrine GeinozPierre-Alain Carrupt
Apr 23, 2004·The Journal of Investigative Dermatology·Beatrice M MagnussonMichael S Roberts
Apr 30, 2004·Journal of Medicinal Chemistry·Peter EttmayerBernard Testa
Jun 9, 2004·Current Opinion in Chemical Biology·Mike M Hann, Tudor I Oprea
Oct 23, 2004·Biochemical Pharmacology·Bernard Testa
Nov 30, 2004·Journal of Medicinal Chemistry·Paul D Leeson, Andrew M Davis
Dec 17, 2004·Nature·Christopher Lipinski, Andrew Hopkins
Feb 4, 2005·Journal of Medicinal Chemistry·Hanne H F RefsgaardMichael S Christensen
Mar 18, 2005·Journal of Medicinal Chemistry·Giulio VistoliBernard Testa
Apr 29, 2005·Journal of Medicinal Chemistry·Yvonne C Martin
Jul 22, 2005·Journal of Medicinal Chemistry·Giulio VistoliBernard Testa
Oct 28, 2005·Journal of Medicinal Chemistry·Giulio VistoliBernard Testa
Jun 9, 2006·Journal of Medicinal Chemistry·Michal Vieth, Jeffrey J Sutherland
Jul 4, 2006·Current Opinion in Chemical Biology·Thomas H KellerZheng Yin
Sep 23, 2006·ChemMedChem·Mario LobellAlexander Hillisch
Dec 29, 2006·Chemistry & Biodiversity·Bernard TestaAlessandro Pedretti
Jan 11, 2007·Nature Biotechnology·Alan C ChengEnoch S Huang
Jan 24, 2007·Journal of Chemical Information and Modeling·Michael C Hutter
Nov 1, 2007·Nature Reviews. Drug Discovery·Paul D Leeson, Brian Springthorpe

❮ Previous
Next ❯

Citations

May 28, 2013·European Journal of Medicinal Chemistry·Rahul IngleSanjay J Surana
Jul 9, 2013·European Journal of Medicinal Chemistry·Saeed EmamiHamid Irannejad
Mar 15, 2011·Molecular Pharmaceutics·Shaoling ZhangShinji Sakuma
Nov 30, 2013·Nature Reviews. Drug Discovery·John G CummingHongming Chen
Jul 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Feng ZhuYuzong Chen
Nov 6, 2013·Biology Direct·Sandeep Kumar DhandaGajendra P S Raghava
Jun 29, 2011·Future Medicinal Chemistry·Giulio VistoliBernard Testa
Dec 20, 2013·Chemical Reviews·Aurora J Cruz-Cabeza, Joel Bernstein
Jul 21, 2014·Nature Chemical Biology·Elizabeth A VillarAdrian Whitty
Dec 3, 2014·Bioorganic & Medicinal Chemistry Letters·Arshi NaqviAnil Kumar Dwivedi
Nov 21, 2013·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·I CruzM L Smith
Jan 27, 2010·Expert Opinion on Therapeutic Patents·Percy H Carter
May 20, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wagdy M EldehnaHatem A Abdel-Aziz
Jan 16, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rosanna SolinasPaul W Baures
Feb 2, 2016·European Journal of Medicinal Chemistry·Charlotte BouckaertLionel Pochet
Jan 24, 2016·Drug Discovery Today·Serge MignaniJean-Pierre Majoral
Sep 27, 2012·Bioorganic & Medicinal Chemistry·Leonardo E RiafrechaPedro A Colinas
Feb 11, 2015·Advanced Drug Delivery Reviews·Sheng TianTingjun Hou
Jul 12, 2011·Bioorganic & Medicinal Chemistry·Alessandro PedrettiGiulio Vistoli
Jul 5, 2011·Bioorganic & Medicinal Chemistry Letters·Oscar M RodríguezClaudiu T Supuran
Jul 26, 2014·Journal of Medicinal Chemistry·Keith C CoffmanMark J Kurth
May 22, 2010·Journal of Molecular Graphics & Modelling·Xi ZhouXin Chen
Aug 22, 2009·Chemistry & Biodiversity·Giulio VistoliBernard Testa
Aug 22, 2009·Chemistry & Biodiversity·Bernard TestaAndrzej J Bojarski
Nov 26, 2009·Chemistry & Biodiversity·Han van de Waterbeemd
Aug 18, 2009·ChemMedChem·Carlotta GranchiFilippo Minutolo
Jun 1, 2011·Molecular Informatics·Gefei HaoGuangfu Yang
Sep 23, 2014·Chemistry & Biodiversity·Bernard TestaAlessandro Pedretti
Aug 26, 2014·Journal of Pharmaceutical and Biomedical Analysis·Maria G KouskouraCatherine K Markopoulou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.